Biomark Res
Biomarker Research, with ISSN 2050-7771, is a prominent peer-reviewed, open access journal dedicated to the rapidly evolving field of biomarker discovery and application. Published by BioMed Central (part of Springer Nature), the journal serves as a premier platform for the dissemination of groundbreaking findings across all stages of biomarker development, from initial identification and validation to clinical translation and implementation. Its scope encompasses a broad spectrum of molecular and cellular biomarkers, including genomic, proteomic, metabolomic, and imaging-based indicators, with a particular emphasis on their utility in disease diagnosis, prognosis, therapeutic monitoring, and personalized medicine. The journal welcomes a range of article types, including original research articles, comprehensive reviews, short reports, and methodology papers, all subjected to rigorous peer review. The target audience is multidisciplinary, comprising clinical researchers, translational scientists, oncologists, pharmacologists, and bioinformaticians seeking authoritative, high-impact data to guide both laboratory investigations and clinical practice. Notably, Biomarker Research is fully open access, ensuring that all published content is freely and permanently available online, thereby maximizing global visibility and knowledge exchange. With an impressive 2026 Impact Factor of 8.6330, the journal is firmly positioned in the JCR Q1 quartile, reflecting its exceptional citation impact and high standing within the field of medical laboratory technology and oncology. This combination of a robust impact factor, open access model, and focused scope establishes Biomarker Research as a leading and essential resource for cutting-edge advances in biomarker science.